Portal de Periódicos da CAPES

Patient information and consent in trials for the treatment of benign prostatic obstruction

2000; Wiley; Volume: 85; Issue: s1 Linguagem: Inglês

10.1046/j.1464-410x.2000.00042.x

1464-410X

Andrew C. Thorpe, David E. Neal,

Prostate Cancer Diagnosis and Treatment

BJU InternationalVolume 85, Issue s1 p. 42-45 Patient information and consent in trials for the treatment of benign prostatic obstruction A.C. Thorpe, A.C. Thorpe Department of Urology, Sunderland Royal Hospital, Sunderland, andSearch for more papers by this authorD.E. Neal, D.E. Neal Freeman Hospital and Department of Surgery, The Medical School, University of Newcastle, Newcastle upon Tyne, UKSearch for more papers by this author A.C. Thorpe, A.C. Thorpe Department of Urology, Sunderland Royal Hospital, Sunderland, andSearch for more papers by this authorD.E. Neal, D.E. Neal Freeman Hospital and Department of Surgery, The Medical School, University of Newcastle, Newcastle upon Tyne, UKSearch for more papers by this author First published: 27 August 2008 https://doi.org/10.1046/j.1464-410x.2000.00042.xCitations: 2 A.C. Thorpe, Sunderland Royal Hospital, Kyall Rd, Sunderland, SR4 7TP. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Horton R. Surgical research or comic opera: Questions but few answers. Lancet 1996; 347: 984–5 2 Downs SH, Black NA, Devlin HB, Royston CMS, Russel RCG. Systematic review of the effectiveness and safety of laparascopic cholecystectomy. Ann R Coll Surg Eng 1996; 3: 241–90 3 Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. New Eng J Med 1989; 320: 1120–4 4 Te-slaa EE, Francisca EA, Henkriks JC, Kierneney LA, Debruyne FM, De La Rosette JJ. Quality of life assessment in patients after laser prostatectomy. Br J Urol 1997; 80: 211–6 5 Ramon J, Lynch TH, Eardley I et al. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia, a collaborative multicentre study. Br J Urol 1997; 80: 128–34 6 Nakamura K, Baba S, Saito S et al. High intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate 200. J Endourol 1997; 11: 197–201 7 D’Ancona FC, Francisca EA, Debruyne FM, De La Rosette JJ. High energy transurethral microwave therapy in men with lower urinary tract symptoms. J Endourol 1997; 11: 285–9 8 Lepor H, Wo W, Barry MJ. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veteran affairs co-operative studies Benign Prostatic Hyperplasia study group. J Urol 1998; 160: 1358–67 9 Buzelin JM, Delauche-cavallier MC, Roth S . Clinical uroselectivity: evidence from patients treated with slow release alfuzosin on symptomatic benign prostatic obstruction. Br J Urol 1997; 79: 898–904 10 Michel MC, Mehlburger L, Bressel HU et al. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does comorbidity alter tolerability. J Urol 1998; 160: 784–91 11 Roehrborn CG, Oesterling JE, Olson PJ, Padley RJ. Serial PSA measurements in men with clinically benign prostatic hyperplasia during a twelve month placebo controlled study with terazosin. HYCAT investigator group. Urology 1997; 50: 556–61 12 Peto R, Baigent C. Trials: the next 50 years. Br Med J 1998; 317: 1170–1 13 Brown L. GCP and informed consent: a UK perspective. Good Clin Prac J 1994; 1: 20–33 14 Smith T. Information for patients, writing simple English is difficult, even for doctors. Br Med J 1992; 305: 1242 15 Wager E, Tooley PJH, Emanuel MB, Wood SF. Get patients’ consent to enter clinical trials. Br Med J 1995; 311: 734–7 16 Meredith P, Emberton M. Urinary disorders and male health; a decision making guide for patients. CD-ROM for Windows. Royal College of Surgeons of England. London: Macromedia, 1998 17 Thorpe AC, Cleary R, Coles J, Reynolds J, Vernon S, Neal DE. Written consent about sexual function in men undergoing transurethral prostatectomy. Br J Urol 1994; 74: 559–65 18 Dawes P, Davison P. Informed consent: what do patients want to know? J R Soc Med 1994; 87: 149–52 19 Kerrigan DD, Therasayagam RS, Wood TO et al. Who’s afraid of informed consent? Br Med J 1993; 306: 298–300 20 Kessel A. On failing to understand informed consent. Br J Hosp Med 1994; 52: 235–8 21 Royal College of Physicians. Research involving patients. London: Royal College of Physicians, 1990 22 Roberson NL. Clinical participation: Viewpoints from racial/ethnic groups. Cancer 1994; 74: 2687–91 23 Featherstone K, Donovan JL. Random allocation or allocation at random? Patients perspectives of participation in a randomised controlled trial. Br Med J 1998; 317: 24 Citing Literature Volume85, Issues1March 2000Pages 42-45 ReferencesRelatedInformation